FDA Approves Daraxonrasib Breakthrough Pancreatic Cancer Drug
FDA Approves Daraxonrasib: A Landmark Moment in Pancreatic Cancer Treatment On August 26, 2026, the U.S. Food and Drug Administration
Read more
Cancer
FDA Approves First RAS-Targeted Drug for Pancreatic Cancer
FDA Approves First RAS-Targeted Drug for Pancreatic Cancer On August 26, 2026, the U.S. Food and Drug Administration granted approval
Read more
Moderna and Merck mRNA Cancer Vaccine Shows Breakthrough Results in Melanoma Trial
In what medical experts are calling one of the most significant oncology breakthroughs of the decade, Moderna and Merck have
Read more